Concepedia

Gulam Latiff

GL

Statistics

Publications

12

Citations

4.6K

H-Index

12

Active since

1992

Affiliations

AIDS Research Consortium of Atlanta(Current)

GlaxoSmithKline (United States)

Icahn School of Medicine at Mount Sinai

Universidad de Guadalajara

University of Toronto

Gulam Latiff is an author at AIDS Research Consortium of Atlanta specializing in medicine, metabolic syndrome, and cardiovascular disease.

Top concepts

Publications per year

1992–2023

12

Publications

12

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

, , +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

, , +10

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression

Susan Swindells, Jaime Andrade‐Villanueva, Gary Richmond et al. · New England Journal of Medicine · 2020 · 523 citations · Full text

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Judith A. Aberg, Gilles Pialoux, Pedro Cahn et al. · New England Journal of Medicine · 2020 · 169 citations · Full text

, , +14

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Giuliano Rizzardini, Edgar T. Overton, Chloe Orkin et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2020 · 137 citations · Full text

1–5 of 12